COPD Maintenance Therapy with Tiotropium/Olodaterol Compared with Tiotropium: An Analysis in the Absence of Additional ICS Therapy

Peter M. A. Calverleya Clinical Science Centre, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK; Correspondence[email protected]
View further author information

Alberto de la Hozb Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany; View further author information

Wenqiong Xuec Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT, USA; View further author information

Gary T. Fergusond Pulmonary Research Institute of Southeast Michigan, Farmington Hills, MI, USA; View further author information

Marc Miravitllese Pneumology Department, Hospital Universitari Vall d'Hebron/Vall d'Hebron Research Institute (VHIR), CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain

https://orcid.org/0000-0002-9850-9520 View further author information

COPD Maintenance Therapy with Tiotropium/Olodaterol Compared with Tiotropium: An Analysis in the Absence of Additional ICS Therapy

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

COPD Maintenance Therapy with Tiotropium/Olodaterol Compared with Tiotropium: An Analysis in the Absence of Additional ICS Therapy

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date